Retrospective Study of Hepatotoxicity of Gemcitabine （Gemzar®）as First-line Chemotherapy in Non-Small Cell Lung Cancer

Retrospective Study of Hepatotoxicity of Gemcitabine （Gemzar®）as First-line Chemotherapy in Non-Small Cell Lung Cancer

碩士 === 國立臺灣大學 === 臨床藥學研究所 === 93 === Gemcitabine (Gemzar®) is one of the standard drugs used in patients with advanced non-small cell lung cancer. Compared with other cytotoxic agents, gemcitabine displayed minimal toxicity. Hepatotoxicity occurred frequently (about 20~50%) and was manifest as a tra...

Full description

Bibliographic Details
Main Authors:	Ying-Hui Wu, 吳盈慧
Other Authors:	楊志新
Format:	Others
Language:	zh-TW
Published:	2005
Online Access:	http://ndltd.ncl.edu.tw/handle/61838921972542661124

Similar Items

Gemzar (gemtsitabin) v lechenii nemelkokletochnogo raka legkogo
by: M B Bychkov, et al.
Published: (2001-06-01)

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study
by: Minami S, et al.
Published: (2015-09-01)

Efficacy of Gemcitabine and Vinorelbine in First-line Treatment  with Advanced Non-small Cell Lung Cancer: A Multicentre Retrospective Study
by: Yongfeng YU, et al.
Published: (2012-05-01)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
by: Zoli Wainer, et al.
Published: (2008-10-01)

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study
by: Shinogu Takashima, et al.
Published: (2020-10-01)

A Randomized Study of Gemcitabine plus Oxaliplatin  versus Gemcitabine plus Cisplatin as the 1st Line Chemotherapy  for Advanced Non-small Cell Lung Cancer in Elderly Patients
by: Zhixi LI, et al.
Published: (2011-07-01)

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules
by: Francesca Foschini, et al.
Published: (2020-09-01)

Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
by: Ai D, et al.
Published: (2016-09-01)

First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients
by: Ying Li, et al.
Published: (2014-01-01)

Gemzar v kombinatsii s tsisplatinom v terapii infil'trativnykh form raka mochevogo puzyrya
by: A A Arzumanov, et al.
Published: (2004-03-01)

The Changes of the first-line Chemotherapy on Advanced non-small Cell Lung Cancer
by: Baohui HAN, et al.
Published: (2008-04-01)

Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
by: Naiki T, et al.
Published: (2018-09-01)

Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
by: Alexander Dechêne, et al.
Published: (2020-11-01)

A meta Analysis of Gemcitabine plus Platinum Chemotherapy Compared with Single-agent Chemotherapy in the Treatment of Non-small Cell Lung Cancer
by: Lei JIANG, et al.
Published: (2010-03-01)

Randomize Trial of Cisplatin plus Gemcitabine with either Sorafenib or Placebo as First-line Therapy for Non-small Cell Lung Cancer
by: Yan WANG, et al.
Published: (2011-03-01)

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study
by: Lu Zou, et al.
Published: (2021-07-01)

Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer
by: Liming Sheng, et al.
Published: (2019-12-01)

A meta-analysis of Pemetrexed plus Platinum Chemotherapy versus Gemcitabine plus Platinum Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Jin JIANG, et al.
Published: (2011-01-01)

A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
by: Samir Shehata, et al.
Published: (2010-01-01)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
by: Zarogoulidis K, et al.
Published: (2013-10-01)

Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy)
by: V A Gorbunova, et al.
Published: (2010-09-01)

Advances of Drug Resistance Marker of Gemcitabine for Non-small Cell Lung Cancer
by: Baorui LIU, et al.
Published: (2011-05-01)

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
by: Courèche-Guillaume Kaderbhai, et al.
Published: (2017-09-01)

Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
by: Toshihiro Shiozawa, et al.
Published: (2018-09-01)

A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer
by: Peter Driesen, et al.
Published: (2013-05-01)

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer
by: Panpan Jiang, et al.
Published: (2021-09-01)

Retrospective Study of Treatment Costs in Patients with Stage IIIB or IV Non-Small Cell Lung Cancer Who Were Treated with First Line Combination Chemotherapy
by: Hsiang-Ju Cheng, et al.
Published: (2007)

First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience
by: Emrah Eraslan, et al.
Published: (2019-04-01)

Clinical outcome of gemcitabine and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with methotrexate, vinblastine, doxorubicin, and cisplatin
by: J. Furukawa, et al.
Published: (2020-07-01)

Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
by: Effendi WI, et al.
Published: (2019-04-01)

Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China
by: You R, et al.
Published: (2019-12-01)

Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.
by: Xiaopeng Dong, et al.
Published: (2014-01-01)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy
by: Hao Wang, et al.
Published: (2020-04-01)

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study
by: Kazuhito Mita, et al.
Published: (2010-12-01)

Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
by: Ye Tian, et al.
Published: (2018-06-01)

Relations between RRM1 Protein Expression Levels and Effects of Gemcitabine and Cisplatin Chemotherapy in Advanced Non-small Cell Lung Cancer Patients
by: Zhiqiang GAO, et al.
Published: (2011-04-01)

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Sitong Guo, et al.
Published: (2021-01-01)

Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
by: Filipe Rocha Da Silva, et al.
Published: (2018-05-01)

Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
by: Akinaru Yamamoto, et al.
Published: (2020-11-01)

Gemcitabine Combined with Vinorelbine in the Treatment of Refractory Patients with Advanced Non-small Cell Lung Cancer: A Multi-center Retrospective Study
by: Shun LU, et al.
Published: (2012-09-01)